185 related articles for article (PubMed ID: 22069577)
21. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.
DiFranco KM; Johnson-Farley N; Bertino JR; Elson D; Vega BA; Belinka BA; Kachlany SC
Leuk Res; 2015 Jun; 39(6):649-56. PubMed ID: 25850729
[TBL] [Abstract][Full Text] [Related]
22. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.
Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC
Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197
[TBL] [Abstract][Full Text] [Related]
23. Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.
Krueger E; Brown AC
Mol Oral Microbiol; 2020 Jun; 35(3):85-105. PubMed ID: 32061022
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Applications of
Kachlany SC; Vega BA
Pathogens; 2024 Apr; 13(5):. PubMed ID: 38787206
[No Abstract] [Full Text] [Related]
25. Screen for leukotoxin mutants in Aggregatibacter actinomycetemcomitans: genes of the phosphotransferase system are required for leukotoxin biosynthesis.
Isaza MP; Duncan MS; Kaplan JB; Kachlany SC
Infect Immun; 2008 Aug; 76(8):3561-8. PubMed ID: 18541661
[TBL] [Abstract][Full Text] [Related]
26. Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization.
Brown AC; Boesze-Battaglia K; Du Y; Stefano FP; Kieba IR; Epand RF; Kakalis L; Yeagle PL; Epand RM; Lally ET
Cell Microbiol; 2012 Jun; 14(6):869-81. PubMed ID: 22309134
[TBL] [Abstract][Full Text] [Related]
27. Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans.
Balashova NV; Park DH; Patel JK; Figurski DH; Kachlany SC
Infect Immun; 2007 Sep; 75(9):4490-7. PubMed ID: 17635874
[TBL] [Abstract][Full Text] [Related]
28. Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function-associated antigen 1.
Nygren P; Balashova N; Brown AC; Kieba I; Dhingra A; Boesze-Battaglia K; Lally ET
Cell Microbiol; 2019 Mar; 21(3):e12967. PubMed ID: 30329215
[TBL] [Abstract][Full Text] [Related]
29. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.
Crosby JA; Kachlany SC
Gene; 2007 Feb; 388(1-2):83-92. PubMed ID: 17116373
[TBL] [Abstract][Full Text] [Related]
30. Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.
Kachlany SC; Schwartz AB; Balashova NV; Hioe CE; Tuen M; Le A; Kaur M; Mei Y; Rao J
Leuk Res; 2010 Jun; 34(6):777-85. PubMed ID: 19747730
[TBL] [Abstract][Full Text] [Related]
31. Bacterial RTX toxins allow acute ATP release from human erythrocytes directly through the toxin pore.
Skals M; Bjaelde RG; Reinholdt J; Poulsen K; Vad BS; Otzen DE; Leipziger J; Praetorius HA
J Biol Chem; 2014 Jul; 289(27):19098-109. PubMed ID: 24860098
[TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
Chang EH; Brown AC
J Pharm Pharmacol; 2021 Mar; 73(4):505-514. PubMed ID: 33793838
[TBL] [Abstract][Full Text] [Related]
33. Cranberry Proanthocyanidins Neutralize the Effects of
Ben Lagha A; Howell A; Grenier D
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
[No Abstract] [Full Text] [Related]
34. A comparison of Aggregatibacter actinomycetemcomitans (Aa) virulence traits in a rat model for periodontal disease.
Schreiner H; Li Y; Cline J; Tsiagbe VK; Fine DH
PLoS One; 2013; 8(7):e69382. PubMed ID: 23936002
[TBL] [Abstract][Full Text] [Related]
35. Aggregatibacter actinomycetemcomitans leukotoxin is post-translationally modified by addition of either saturated or hydroxylated fatty acyl chains.
Fong KP; Tang HY; Brown AC; Kieba IR; Speicher DW; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2011 Aug; 26(4):262-76. PubMed ID: 21729247
[TBL] [Abstract][Full Text] [Related]
36.
Lally ET; Boesze-Battaglia K; Dhingra A; Gomez NM; Lora J; Mitchell CH; Giannakakis A; Fahim SA; Benz R; Balashova N
Pathogens; 2020 Jan; 9(2):. PubMed ID: 31973183
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.
Brown AC; Koufos E; Balashova NV; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):94-105. PubMed ID: 26352738
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Bacterial Toxin Activity by the Nuclear Stain, DRAQ5™.
Webb JN; Koufos E; Brown AC
J Membr Biol; 2016 Aug; 249(4):503-11. PubMed ID: 27039399
[TBL] [Abstract][Full Text] [Related]
39. Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans.
Balashova NV; Crosby JA; Al Ghofaily L; Kachlany SC
Infect Immun; 2006 Apr; 74(4):2015-21. PubMed ID: 16552030
[TBL] [Abstract][Full Text] [Related]
40. Catechin-mediated restructuring of a bacterial toxin inhibits activity.
Chang EH; Huang J; Lin Z; Brown AC
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):191-198. PubMed ID: 30342156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
